Mounjaro (Tirzepatide) is a licensed weight loss injection. Mounjaro is a dual action medication which directly activates GIP and GLP-1.
GLP-1 helps users by making them feel a reduction in appetite, promoting a feeling of fullness and delaying stomach emptying by binding to GLP-1 receptors in the body. GIP helps to reduce fat accumulation, increase bone formation and glucagon production and also reduces stomach acid.
Mounjaro is made by US Pharmaceutical company Eli Lilly
